Company Profile

Vista Scientific LLC
Profile last edited on: 3/28/17      CAGE: 3P2Z0      UEI:

Business Identifier: technologies for ophthalmic product development
Year Founded
1996
First Award
1999
Latest Award
2010
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1 Dundee Park Suite 8B
Andover, MA 01810
   (978) 474-4491
   cleahy@vistasci.com
   www.vistasci.com
Location: Single
Congr. District: 03
County: Essex

Public Profile

Vista Scientific LLC is a product development company specializing in solutions for the general eye care market. With the focus on drug delivery though eyes, principals note the messiness of drops, difficulty of dosage control, side effects, required high drug concentration etc. Instead they offer non-invasive topical system using nanosphere -antibiotic corneal contact lenses. Sustained release over time, biodegradable and non toxic. Vista Scientific LLC is focussed on novel therapies for specific ocular diseases and have pursued two primary development avenues: new therapeutic agents and new drug delivery technology. Vista’s experienced team of key R&D, clinical and marketing personnel has worked closely together for twenty years and have a successful track record in bringing products to market, particularly in the ophthalmic field. Additionally, the firm maintains strong academic ties with institutions and have collaborated with MIT, University of Massachusetts, University of Utah and Schepens Eye Research Institute

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2010 2 NIH $2,529,066
Project Title: Ocular Insert For The Treatment Of Glaucoma
2009 2 NIH $357,146
Project Title: Nanosphere-Antibiotic Corneal Contact Lens Delivery System
2004 1 NIH $100,000
Project Title: Overnight Orthokeratology Contact Lens Manufacture
2002 2 NIH $985,360
Project Title: Development Of A Biopolymer Based Tear Film Supplement

Key People / Management

  Robert F Thompson -- President

  Kathryn S Crawford

  Edward J Ellis

  Jeanne Y Ellis

  Charles D Leahy -- Founder, Vice President, Medical Affairs

Company News

There are no news available.